These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 2162638)

  • 1. Efficacy of betaxolol in the treatment of stable exertional angina pectoris: a dose-ranging study.
    Alpert MA; Mukerji V; Villarreal D; Singh A; Flaker GC; Sanfelippo JF; Beach CL; Morgan RJ
    Angiology; 1990 May; 41(5):365-76. PubMed ID: 2162638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta blockade with betaxolol on left ventricular systolic function in chronic stable angina pectoris and left ventricular dysfunction.
    Alpert MA; Singh A; Holmes RA; Sanfelippo JF; Flaker GC; Villarreal D; Mukerji V; Morgan RJ
    Am J Cardiol; 1986 Apr; 57(10):721-4. PubMed ID: 2870631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group.
    Narahara KA
    Am J Cardiol; 1990 Mar; 65(9):577-82. PubMed ID: 2178381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour beta-blockade in stable angina pectoris: a study of atenolol and betaxolol.
    McLenachan JM; Findlay IN; Wilson JT; Dargie HJ
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):311-5. PubMed ID: 1381024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Betaxolol in the treatment of stable angina pectoris.
    Chrysant SG; Bittar N
    Cardiology; 1994; 84(4-5):316-21. PubMed ID: 8187119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris.
    Glasser SP; Friedman R; Talibi T; Smith LK; Weir EK
    Am J Cardiol; 1994 Feb; 73(4):213-8. PubMed ID: 8296748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.
    Kardas P
    Vasc Health Risk Manag; 2007; 3(2):235-42. PubMed ID: 17580734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardioselective beta-adrenoblockers in patients with stable angina pectoris. Comparison of efficacy and safety].
    Dupliakov DV; Glukhova VL; Vozhdaeva ZI; Golovina GA
    Ter Arkh; 2006; 78(9):43-8. PubMed ID: 17076224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose related efficacy of betaxolol in combination with nitroglycerin in patients with angina pectoris: a double blind cross-over study.
    Stroobandt R; Kesteloot H
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):299-309. PubMed ID: 6143538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-blockade on right ventricular performance in patients with and without right ventricular dysfunction due to coronary artery disease.
    Singh A; Alpert MA; Sanfelippo JF; Mukerji V; Villarreal D; Holmes RA; Sunderrajan EV; Morgan RJ
    Arch Intern Med; 1986 Nov; 146(11):2135-9. PubMed ID: 2877643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris.
    Khurmi NS; Bowles MJ; O'Hara MJ; Lahiri A; Raftery EB
    Int J Cardiol; 1985 Nov; 9(3):289-302. PubMed ID: 3902675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta adrenergic receptor blockade on cardiac autonomic tone in patients with chronic stable angina.
    Burger AJ; Kamalesh M; Kumar S; Nesto R
    Pacing Clin Electrophysiol; 1996 Apr; 19(4 Pt 1):411-7. PubMed ID: 8848388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol.
    Irvine NA; Lipworth BJ; McDevitt DG
    Br J Clin Pharmacol; 1990 Jul; 30(1):119-26. PubMed ID: 1975196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atenolol on treadmill performance in patients with angina pectoris.
    Kritzer G; Warr TA; Strong ML; Froelicher VF
    Clin Pharm; 1983; 2(3):236-42. PubMed ID: 6349909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diltiazem in chronic stable angina].
    González-Hermosillo JA; Clemente AC; Salazar E
    Arch Inst Cardiol Mex; 1986; 56(4):327-32. PubMed ID: 2945527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response effectiveness of propranolol for the treatment of angina pectoris.
    Alderman EL; Davies RO; Crowley JJ; Lopes MG; Brooker JZ; Friedman JP; Graham AF; Matlof HJ; Harrison DC
    Circulation; 1975 Jun; 51(6):964-75. PubMed ID: 805675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta blockade on systolic and diastolic left ventricular function at rest and during exercise in patients with chronic stable angina pectoris.
    Iskandrian AS; Nestico PF; Hakki AH; Heo J; Fernandes M; Fiorentini R; Schenk C
    Am Heart J; 1987 Mar; 113(3):791-8. PubMed ID: 2881478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.